Supreme Court sides with Kirtsaeng on first sale defence

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Supreme Court sides with Kirtsaeng on first sale defence

The Supreme Court disagreed with amici such as AIPLA, IPO and the MPAA on Tuesday when it ruled that Supap Kirtsaeng could lawfully buy cheaper editions of textbooks overseas and then resell them in the US for a profit

The Court said in Kirtsaeng v Wiley & Sons that the first sale doctrine - which states that once a copyright owner sells a work, his rights in that work are exhausted - applies to copies manufactured outside of the United States with the publisher’s permission. The books at issue were manufactured by Wiley & Sons’ foreign subsidiary, Wiley Asia.

The decision has clarified what the US Copyright Act means by “lawfully made under this title”, but many copyright owners and practitioners will undoubtedly be unhappy with its interpretation.

While Wiley read “lawfully made under this title” to mean that the work must have been geo­graphically made in the US under US copyright law, Kirtsaeng argued that it simply meant ‘in accordance with’ or ‘in compliance with’ the Copyright Act, which would permit the doctrine to apply to copies manufactured abroad with the copyright owner’s permission”, wrote the Court.

AIPLA’s amicus brief argued that the first sale defence may not be raised, not because the books were made abroad, but because under the extraterritoriality doctrine the first sale right attaches only after the copyright owner has made its first sale in the United States.

Joshua Rosenkranz of Orrick Herrington & Sutcliffe argued for Kirtsaeng, while Theodore Olson of Gibson Dunn & Crutcher argued for Wiley.

more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article